J.W. Cole Advisors Inc. Grows Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

J.W. Cole Advisors Inc. increased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 87.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,870 shares of the biotechnology company’s stock after buying an additional 2,742 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in Axon Enterprise were worth $3,489,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Nkcfo LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at approximately $166,000. J.P. Marvel Investment Advisors LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at approximately $6,485,000. Allworth Financial LP increased its holdings in Axon Enterprise by 23.5% in the 4th quarter. Allworth Financial LP now owns 1,242 shares of the biotechnology company’s stock valued at $755,000 after purchasing an additional 236 shares during the last quarter. Principal Securities Inc. increased its holdings in Axon Enterprise by 255.7% in the 4th quarter. Principal Securities Inc. now owns 1,085 shares of the biotechnology company’s stock valued at $645,000 after purchasing an additional 780 shares during the last quarter. Finally, Valeo Financial Advisors LLC increased its holdings in Axon Enterprise by 4.1% in the 4th quarter. Valeo Financial Advisors LLC now owns 1,084 shares of the biotechnology company’s stock valued at $644,000 after purchasing an additional 43 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity

In related news, insider Jeffrey C. Kunins sold 2,304 shares of the stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the transaction, the insider now directly owns 128,542 shares of the company’s stock, valued at $84,168,016.18. This represents a 1.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 8,711 shares of company stock valued at $5,631,561. Insiders own 6.10% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $683.41 on Monday. The company has a 50-day simple moving average of $623.22 and a 200-day simple moving average of $509.17. Axon Enterprise, Inc. has a one year low of $260.27 and a one year high of $698.67. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a market capitalization of $52.11 billion, a price-to-earnings ratio of 176.59, a PEG ratio of 6.79 and a beta of 1.05.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on AXON. Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Needham & Company LLC boosted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. TD Cowen assumed coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. Finally, JMP Securities boosted their price target on shares of Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a research note on Tuesday, February 4th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $542.15.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.